CELLULAR SCHWANNOMAS OF THE INTRACRANIAL AND INTRASPINAL COMPARTMENT - MORPHOLOGICAL AND IMMUNOLOGICAL CHARACTERISTICS COMPARED WITH CLASSICAL BENIGN SCHWANNOMAS

被引:21
作者
DERUAZ, JP [1 ]
JANZER, RC [1 ]
COSTA, J [1 ]
机构
[1] UNIV LAUSANNE,INST PATHOL,DIV NEUROPATHOL,CH-1011 LAUSANNE,SWITZERLAND
关键词
CELLULAR SCHWANNOMAS; PERIPHERAL NERVOUS SYSTEM; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMORS;
D O I
10.1097/00005072-199303000-00003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The concept of cellular schwannoma as an unusual benign tumor is well established for peripheral nerves but has never been tested in neurosurgical series. In order to test the validity of this concept in cranial nerves and spinal roots we performed an analysis of the clinical and morphological characteristics of 12 cellular and 166 classical benign schwannomas. Immunohistochemical detection of antigen expression in Schwann cells including proliferating cell nuclear antigen (PCNA) was also performed. This study shows that cellular schwannomas in neurosurgical series manifest at a lower age than the classical benign variant and occur mainly in the spinal roots. Mitotic activity and sinusoidal vessels appear more frequently in cellular schwannomas and constitute with high cellularity, the most valuable criteria separating both entities. The postoperative course in both types of tumors was free of metastases or sarcomatous changes. Immunoexpression of S-100 protein, vimentin, epithelial membrane antigen and glial fibrillary acidic protein is not statistically different between the two variants. In contrast, PCNA is more highly expressed in cellular schwannomas. These results confirm the concept that cellular schwannomas are a clinico-pathological variant of benign schwannomas and provide significant support for the introduction of this entity in neurosurgical oncology.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 18 条
[1]  
COSTA J, 1984, CANCER, V53, P530, DOI 10.1002/1097-0142(19840201)53:3<530::AID-CNCR2820530327>3.0.CO
[2]  
2-D
[3]  
DUCATMAN BS, 1986, CANCER-AM CANCER SOC, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO
[4]  
2-6
[5]  
Fletcher C, 1990, PATHOBIOLOGY SOFT TI, P221
[6]  
FLETCHER CDM, 1987, HISTOPATHOLOGY, V11, P21
[7]  
GRANT JW, 1992, 14TH M SWISS NEUR ST
[8]   PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IMMUNOLOCALIZATION IN PARAFFIN SECTIONS - AN INDEX OF CELL-PROLIFERATION WITH EVIDENCE OF DEREGULATED EXPRESSION IN SOME NEOPLASMS [J].
HALL, PA ;
LEVISON, DA ;
WOODS, AL ;
YU, CCW ;
KELLOCK, DB ;
WATKINS, JA ;
BARNES, DM ;
GILLETT, CE ;
CAMPLEJOHN, R ;
DOVER, R ;
WASEEM, NH ;
LANE, DP .
JOURNAL OF PATHOLOGY, 1990, 162 (04) :285-294
[9]   MOLECULAR IDENTITY, DISTRIBUTION AND HETEROGENEITY OF GLIAL FIBRILLARY ACIDIC PROTEIN - AN IMMUNOBLOTTING AND IMMUNOHISTOCHEMICAL STUDY OF SCHWANN-CELLS, SATELLITE CELLS, ENTERIC GLIA AND ASTROCYTES [J].
JESSEN, KR ;
THORPE, R ;
MIRSKY, R .
JOURNAL OF NEUROCYTOLOGY, 1984, 13 (02) :187-200
[10]  
JOHNSON L F, 1992, Current Opinion in Cell Biology, V4, P149, DOI 10.1016/0955-0674(92)90025-8